Name: BBIO Balance Sheet - Bridgebio Pharma Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

BBIO - Bridgebio Pharma, Inc.

USD | NASDAQ | Healthcare

BBIO Balance Sheet - Bridgebio Pharma Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash And Short Term Investments
Cash And Equivalents	570.1	681.1	375.9	376.7	393.8	356.1	363.8	436.1	92.0	-
Restricted Cash	0.6	0.1	16.7	37.9	0.2	0.1	-	-	-	-
Short Term Investments	-	-	0.0	51.6	393.7	251.0	182.2	-	-	-
Cash And Short Term Investments	570.1	681.1	375.9	428.3	787.5	607.1	546.0	436.1	92.0	-
Receivables
Accounts Receivable	139.4	4.7	1.8	-	-	-	-	-	-	-
Current Assets
Inventory	26.8	0.0	-	-	-	-	-	-	-	-
Prepaid Expenses	44.1	34.9	24.3	21.9
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-
Current Liabilities
Accounts Payable	36.2	9.6	10.7	11.6	11.9	8.9	8.9	13.5	-	-
Short Term Debt	-	-	-	-
Non-Current Liabilities
Long Term Debt	2,007.3	437.3	446.4	431.0	430.8	92.4	91.8	54.5	-	-
Operating Lease Liabilities Non-Current	3.8	4.7	9.0
Common Equity
Common Stock	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.0
Additional Paid In Capital	2,057.6	1,903.2	-	-
Supplementary Data
Total Debt	2,007.3	437.3	446.4	431.0	430.8	93.9	91.8	54.5	-	-
Net debt	1,437.2	(243.8)	70.5	2.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q4 FY 16
Cash And Short Term Investments
Cash And Equivalents	879.9	570.1	643.0	749.0	540.6	681.1	266.3	408.0	475.2	375.9	505.2	302.4	407.4	376.7	483.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Receivables
Accounts Receivable	205.2	139.4	116.5	76.9	115.3	4.7	-	-	-	-	-	-	-	-	-	-	-	-	-	1.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Current Assets
Inventory	33.0	26.8	24.5	18.3	4.0	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	62.9	44.1	52.4	60.2	35.4	34.9	38.4	28.4	28.1	24.3	22.6	20.5	25.1	21.9	25.7	32.8	34.0	32.4
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	1,241.3	797.7	839.4	912.3	695.2	720.7	444.6	616.2	783.4	477.6	587.7	432.9	552.7	548.9	642.2	771.3

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	4.9	5.4	5.8	6.1	6.7	7.0	8.7	9.8	11.4	11.8	12.4	13.0	13.6	14.6	15.6	16.9
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	61.5	80.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	27.4	28.1	28.8	29.5	27.8	23.9	24.5	25.1	25.7	26.3	26.9	27.5	28.1	28.7	29.3	29.9	30.5
Operating Lease Right Of Use Assets	17.2	8.1	6.6	6.2	7.2	5.8	6.4	7.3	8.1	8.0	9.3	9.8	10.5	10.7	11.7	12.9
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	18.6	16.7	25.5	18.1	16.6	18.2	20.3	18.9	20.7	22.6	18.7	20.4	20.8	20.2	29.9	31.3	35.3
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	1,371.0	936.0	998.3	1,080.2	881.6	919.3	665.0	794.4	849.3	546.4	655.0	503.7	625.7	623.0	728.7	862.2	813.1

Current Liabilities
Accounts Payable	29.1	36.2	18.7	26.1	27.5	9.6	13.4	18.1	4.7	10.7	4.5	3.9	4.1	11.6	10.2	8.8	10.1	11.9	12.0	22.3	10.3	8.9	9.8	12.8	13.1	8.9	10.3	-	-	13.5	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	6.1	7.2	9.1	10.5	11.6	14.6	11.8	15.1	14.0	6.1	6.6	6.2	6.7	8.2	7.5	7.2	-
Operating Lease Liabilities Current	4.4	6.2	5.3	4.8	5.2	4.5	4.6	4.6	4.5	4.1	4.1	3.8	3.7	3.7	4.0	4.3
Accrued Expenses	39.3	76.7	56.2	37.2	33.4	58.3	43.5	29.1	32.4	57.4	33.7	28.7	18.9	31.3	24.8	32.6	15.5	37.0
Other Current Liabilities	135.5	120.2	92.7	65.9	40.7	33.1	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	816.4	288.0	216.6	175.9	152.1	154.4	139.2	134.4	141.5	143.8	106.1	110.1	96.6	121.4	119.2

Non-Current Liabilities
Long Term Debt	2,652.9	-	2,007.3	0.0	0.0	437.3	436.2	435.4	434.7	446.4	441.7	440.5	435.8	431.0	-	-	434.1	430.8	103.1	102.6	90.8	92.4	93.4	92.9	92.4	91.8	75.0	-	-	54.5	-	-	-	-	-
Operating Lease Liabilities Non-Current	14.2	3.8	3.4	4.0	4.9	4.7	5.8	7.1	8.3	9.0	9.8	10.9	11.9	12.3	13.0	14.3
Deferred Revenue Non-Current	11.8	13.1	13.1	14.7	17.5	17.1	18.6	17.0	19.9	3.7	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	0.2	0.2	0.7	0.5	0.4	0.3	0.4	0.5	0.6	5.6	11.8	13.3	17.5	26.6	28.2	28.6
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	3,639.9	3,012.6	2,921.0	2,858.6	2,520.3	2,377.0	1,883.4	1,876.5	1,886.2	1,888.9	1,848.7	1,853.3	1,839.3	1,868.0	1,859.1	1,877.2